Trial Details
COMPLETEDBasic Information
| Clinical ID | c1207 |
|---|---|
| Identifier | NCT01532648 |
| Trial Title | Randomized Placebo-Controlled Trial of Budesonide Multi-Matrix System (MMX) 9 Milligrams (mg) in Participants With Ulcerative Colitis Currently on a 5-Aminosalicylic Acid (5-ASA) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: Budesonide MMX|DRUG: Placebo|DRUG: 5-ASA |
Participant Information
| Sponsor | Bausch Health Americas, Inc. |
|---|---|
| City | Anaheim |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2012-01-27 |
|---|---|
| Primary Completion Date | 2013-10-02 |
| Completion Date | 2013-10-02 |